Global Bacteriophage Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 263 pages | ID: G69A65BB564EEN
Bosson Research

Abstracts

Report Overview

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

This report provides a deep insight into the global Bacteriophage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bacteriophage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bacteriophage Therapy market in any manner.

Global Bacteriophage Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Armata Pharmaceuticals

Inc.

Eliava Biopreparations Ltd.

Pherecydes Pharma

Intralytix

Inc.

Phagelux Inc.

Nextbiotics

InnoPhage

Ltd

Locus Biosciences

Inc.

TechnoPhage

Eligo Bioscience SA

Phagomed Biopharma GmbH.

PhagePro

Inc.

Adaptive Phage Therapeutics

Inc.

EnBiotix

Inc.

Intodeworld

Inc.

BiomX Ltd.

Phi Therapeutics

Fixed-phage Ltd.

Micreos BV

ContraFect Corporation

Market Segmentation (by Type)

Oral

Topical

Parenteral

Market Segmentation (by Application)

Organ Transplantation

Bacterial Infections

Alcoholic Hepatitis

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Bacteriophage Therapy Market
• Overview of the regional outlook of the Bacteriophage Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bacteriophage Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Bacteriophage Therapy
1.2 Key Market Segments
  1.2.1 Bacteriophage Therapy Segment by Type
  1.2.2 Bacteriophage Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL BACTERIOPHAGE THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Bacteriophage Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Bacteriophage Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL BACTERIOPHAGE THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Bacteriophage Therapy Product Life Cycle
3.3 Global Bacteriophage Therapy Sales by Manufacturers (2020-2025)
3.4 Global Bacteriophage Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Bacteriophage Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Bacteriophage Therapy Manufacturing Sites, Area Served, Product Type
3.8 Bacteriophage Therapy Market Competitive Situation and Trends
  3.8.1 Bacteriophage Therapy Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Bacteriophage Therapy Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 BACTERIOPHAGE THERAPY INDUSTRY CHAIN ANALYSIS

4.1 Bacteriophage Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF BACTERIOPHAGE THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Bacteriophage Therapy Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Bacteriophage Therapy Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL BACTERIOPHAGE THERAPY MARKET BY REGION

6.1 Global Bacteriophage Therapy Market Size by Region
  6.1.1 Global Bacteriophage Therapy Market Size by Region
  6.1.2 Global Bacteriophage Therapy Market Size Market Share by Region
6.2 Global Bacteriophage Therapy Sales by Region
  6.2.1 Global Bacteriophage Therapy Sales by Region
  6.2.2 Global Bacteriophage Therapy Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Bacteriophage Therapy Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Bacteriophage Therapy Market Size by Type
7.3 North America Bacteriophage Therapy Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Bacteriophage Therapy Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Bacteriophage Therapy Market Size by Type
8.3 Europe Bacteriophage Therapy Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Bacteriophage Therapy Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Bacteriophage Therapy Market Size by Type
9.3 Asia-Pacific Bacteriophage Therapy Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Bacteriophage Therapy Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Bacteriophage Therapy Market Size by Type
10.3 South America Bacteriophage Therapy Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Bacteriophage Therapy Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Bacteriophage Therapy Market Size by Type
11.3 Middle East and Africa Bacteriophage Therapy Market Size by Application

12 BACTERIOPHAGE THERAPY MARKET PRODUCTION BY REGION

12.1 Global Production of Bacteriophage Therapy by Region(2020-2025)
12.2 Global Bacteriophage Therapy Revenue Market Share by Region (2020-2025)
12.3 Global Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Bacteriophage Therapy Production
  12.4.1 North America Bacteriophage Therapy Production Growth Rate (2020-2025)
  12.4.2 North America Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Bacteriophage Therapy Production
  12.5.1 Europe Bacteriophage Therapy Production Growth Rate (2020-2025)
  12.5.2 Europe Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Bacteriophage Therapy Production (2020-2025)
  12.6.1 Japan Bacteriophage Therapy Production Growth Rate (2020-2025)
  12.6.2 Japan Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Bacteriophage Therapy Production (2020-2025)
  12.7.1 China Bacteriophage Therapy Production Growth Rate (2020-2025)
  12.7.2 China Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2020-2025)

13 BACTERIOPHAGE THERAPY MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Bacteriophage Therapy Sales Market Share by Type (2020-2033)
13.3 Global Bacteriophage Therapy Market Size Market Share by Type (2020-2033)
13.4 Global Bacteriophage Therapy Price by Type (2020-2033)

14 BACTERIOPHAGE THERAPY MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Bacteriophage Therapy Market Sales by Application (2020-2033)
14.3 Global Bacteriophage Therapy Market Size (M USD) by Application (2020-2033)
14.4 Global Bacteriophage Therapy Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Armata Pharmaceuticals
  15.1.1 Armata Pharmaceuticals Basic Information
  15.1.2 Armata Pharmaceuticals Bacteriophage Therapy Product Overview
  15.1.3 Armata Pharmaceuticals Bacteriophage Therapy Product Market Performance
  15.1.4 Armata Pharmaceuticals Business Overview
  15.1.5 Armata Pharmaceuticals SWOT Analysis
  15.1.6 Armata Pharmaceuticals Recent Developments
15.2 Inc.
  15.2.1 Inc. Basic Information
  15.2.2 Inc. Bacteriophage Therapy Product Overview
  15.2.3 Inc. Bacteriophage Therapy Product Market Performance
  15.2.4 Inc. Business Overview
  15.2.5 Inc. SWOT Analysis
  15.2.6 Inc. Recent Developments
15.3 Eliava Biopreparations Ltd.
  15.3.1 Eliava Biopreparations Ltd. Basic Information
  15.3.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Overview
  15.3.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Market Performance
  15.3.4 Eliava Biopreparations Ltd. Business Overview
  15.3.5 Eliava Biopreparations Ltd. SWOT Analysis
  15.3.6 Eliava Biopreparations Ltd. Recent Developments
15.4 Pherecydes Pharma
  15.4.1 Pherecydes Pharma Basic Information
  15.4.2 Pherecydes Pharma Bacteriophage Therapy Product Overview
  15.4.3 Pherecydes Pharma Bacteriophage Therapy Product Market Performance
  15.4.4 Pherecydes Pharma Business Overview
  15.4.5 Pherecydes Pharma Recent Developments
15.5 Intralytix
  15.5.1 Intralytix Basic Information
  15.5.2 Intralytix Bacteriophage Therapy Product Overview
  15.5.3 Intralytix Bacteriophage Therapy Product Market Performance
  15.5.4 Intralytix Business Overview
  15.5.5 Intralytix Recent Developments
15.6 Inc.
  15.6.1 Inc. Basic Information
  15.6.2 Inc. Bacteriophage Therapy Product Overview
  15.6.3 Inc. Bacteriophage Therapy Product Market Performance
  15.6.4 Inc. Business Overview
  15.6.5 Inc. Recent Developments
15.7 Phagelux Inc.
  15.7.1 Phagelux Inc. Basic Information
  15.7.2 Phagelux Inc. Bacteriophage Therapy Product Overview
  15.7.3 Phagelux Inc. Bacteriophage Therapy Product Market Performance
  15.7.4 Phagelux Inc. Business Overview
  15.7.5 Phagelux Inc. Recent Developments
15.8 Nextbiotics
  15.8.1 Nextbiotics Basic Information
  15.8.2 Nextbiotics Bacteriophage Therapy Product Overview
  15.8.3 Nextbiotics Bacteriophage Therapy Product Market Performance
  15.8.4 Nextbiotics Business Overview
  15.8.5 Nextbiotics Recent Developments
15.9 InnoPhage
  15.9.1 InnoPhage Basic Information
  15.9.2 InnoPhage Bacteriophage Therapy Product Overview
  15.9.3 InnoPhage Bacteriophage Therapy Product Market Performance
  15.9.4 InnoPhage Business Overview
  15.9.5 InnoPhage Recent Developments
15.10 Ltd
  15.10.1 Ltd Basic Information
  15.10.2 Ltd Bacteriophage Therapy Product Overview
  15.10.3 Ltd Bacteriophage Therapy Product Market Performance
  15.10.4 Ltd Business Overview
  15.10.5 Ltd Recent Developments
15.11 Locus Biosciences
  15.11.1 Locus Biosciences Basic Information
  15.11.2 Locus Biosciences Bacteriophage Therapy Product Overview
  15.11.3 Locus Biosciences Bacteriophage Therapy Product Market Performance
  15.11.4 Locus Biosciences Business Overview
  15.11.5 Locus Biosciences Recent Developments
15.12 Inc.
  15.12.1 Inc. Basic Information
  15.12.2 Inc. Bacteriophage Therapy Product Overview
  15.12.3 Inc. Bacteriophage Therapy Product Market Performance
  15.12.4 Inc. Business Overview
  15.12.5 Inc. Recent Developments
15.13 TechnoPhage
  15.13.1 TechnoPhage Basic Information
  15.13.2 TechnoPhage Bacteriophage Therapy Product Overview
  15.13.3 TechnoPhage Bacteriophage Therapy Product Market Performance
  15.13.4 TechnoPhage Business Overview
  15.13.5 TechnoPhage Recent Developments
15.14 Eligo Bioscience SA
  15.14.1 Eligo Bioscience SA Basic Information
  15.14.2 Eligo Bioscience SA Bacteriophage Therapy Product Overview
  15.14.3 Eligo Bioscience SA Bacteriophage Therapy Product Market Performance
  15.14.4 Eligo Bioscience SA Business Overview
  15.14.5 Eligo Bioscience SA Recent Developments
15.15 Phagomed Biopharma GmbH.
  15.15.1 Phagomed Biopharma GmbH. Basic Information
  15.15.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Overview
  15.15.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Market Performance
  15.15.4 Phagomed Biopharma GmbH. Business Overview
  15.15.5 Phagomed Biopharma GmbH. Recent Developments
15.16 PhagePro
  15.16.1 PhagePro Basic Information
  15.16.2 PhagePro Bacteriophage Therapy Product Overview
  15.16.3 PhagePro Bacteriophage Therapy Product Market Performance
  15.16.4 PhagePro Business Overview
  15.16.5 PhagePro Recent Developments
15.17 Inc.
  15.17.1 Inc. Basic Information
  15.17.2 Inc. Bacteriophage Therapy Product Overview
  15.17.3 Inc. Bacteriophage Therapy Product Market Performance
  15.17.4 Inc. Business Overview
  15.17.5 Inc. Recent Developments
15.18 Adaptive Phage Therapeutics
  15.18.1 Adaptive Phage Therapeutics Basic Information
  15.18.2 Adaptive Phage Therapeutics Bacteriophage Therapy Product Overview
  15.18.3 Adaptive Phage Therapeutics Bacteriophage Therapy Product Market Performance
  15.18.4 Adaptive Phage Therapeutics Business Overview
  15.18.5 Adaptive Phage Therapeutics Recent Developments
15.19 Inc.
  15.19.1 Inc. Basic Information
  15.19.2 Inc. Bacteriophage Therapy Product Overview
  15.19.3 Inc. Bacteriophage Therapy Product Market Performance
  15.19.4 Inc. Business Overview
  15.19.5 Inc. Recent Developments
15.20 EnBiotix
  15.20.1 EnBiotix Basic Information
  15.20.2 EnBiotix Bacteriophage Therapy Product Overview
  15.20.3 EnBiotix Bacteriophage Therapy Product Market Performance
  15.20.4 EnBiotix Business Overview
  15.20.5 EnBiotix Recent Developments
15.21 Inc.
  15.21.1 Inc. Basic Information
  15.21.2 Inc. Bacteriophage Therapy Product Overview
  15.21.3 Inc. Bacteriophage Therapy Product Market Performance
  15.21.4 Inc. Business Overview
  15.21.5 Inc. Recent Developments
15.22 Intodeworld
  15.22.1 Intodeworld Basic Information
  15.22.2 Intodeworld Bacteriophage Therapy Product Overview
  15.22.3 Intodeworld Bacteriophage Therapy Product Market Performance
  15.22.4 Intodeworld Business Overview
  15.22.5 Intodeworld Recent Developments
15.23 Inc.
  15.23.1 Inc. Basic Information
  15.23.2 Inc. Bacteriophage Therapy Product Overview
  15.23.3 Inc. Bacteriophage Therapy Product Market Performance
  15.23.4 Inc. Business Overview
  15.23.5 Inc. Recent Developments
15.24 BiomX Ltd.
  15.24.1 BiomX Ltd. Basic Information
  15.24.2 BiomX Ltd. Bacteriophage Therapy Product Overview
  15.24.3 BiomX Ltd. Bacteriophage Therapy Product Market Performance
  15.24.4 BiomX Ltd. Business Overview
  15.24.5 BiomX Ltd. Recent Developments
15.25 Phi Therapeutics
  15.25.1 Phi Therapeutics Basic Information
  15.25.2 Phi Therapeutics Bacteriophage Therapy Product Overview
  15.25.3 Phi Therapeutics Bacteriophage Therapy Product Market Performance
  15.25.4 Phi Therapeutics Business Overview
  15.25.5 Phi Therapeutics Recent Developments
15.26 Fixed-phage Ltd.
  15.26.1 Fixed-phage Ltd. Basic Information
  15.26.2 Fixed-phage Ltd. Bacteriophage Therapy Product Overview
  15.26.3 Fixed-phage Ltd. Bacteriophage Therapy Product Market Performance
  15.26.4 Fixed-phage Ltd. Business Overview
  15.26.5 Fixed-phage Ltd. Recent Developments
15.27 Micreos BV
  15.27.1 Micreos BV Basic Information
  15.27.2 Micreos BV Bacteriophage Therapy Product Overview
  15.27.3 Micreos BV Bacteriophage Therapy Product Market Performance
  15.27.4 Micreos BV Business Overview
  15.27.5 Micreos BV Recent Developments
15.28 ContraFect Corporation
  15.28.1 ContraFect Corporation Basic Information
  15.28.2 ContraFect Corporation Bacteriophage Therapy Product Overview
  15.28.3 ContraFect Corporation Bacteriophage Therapy Product Market Performance
  15.28.4 ContraFect Corporation Business Overview
  15.28.5 ContraFect Corporation Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Bacteriophage Therapy Market Size by Type (M USD)
Table 4. Global Bacteriophage Therapy Market Size by Application (M USD)
Table 5. Bacteriophage Therapy Market Size Comparison by Region (M USD)
Table 6. Global Bacteriophage Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Bacteriophage Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Bacteriophage Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Bacteriophage Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2024)
Table 11. Global Market Bacteriophage Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Bacteriophage Therapy Manufacturing Sites and Area Served
Table 13. Manufacturers Bacteriophage Therapy Product Type
Table 14. Global Bacteriophage Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bacteriophage Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Bacteriophage Therapy Market Size Comparison by Region (M USD)
Table 26. Global Bacteriophage Therapy Market Size by Region (2020-2033) & (M USD)
Table 27. Global Bacteriophage Therapy Market Size Market Share by Region (2020-2033)
Table 28. Global Bacteriophage Therapy Sales by Region (2020-2033) & (K Units)
Table 29. Global Bacteriophage Therapy Sales Market Share by Region (2020-2033)
Table 30. North America Bacteriophage Therapy Market Size by Country (2020-2033) & (M USD)
Table 31. North America Bacteriophage Therapy Sales by Country (2020-2033) & (K Units)
Table 32. North America Bacteriophage Therapy Sales by Type (K Units)
Table 33. North America Bacteriophage Therapy Market Size by Type (M USD)
Table 34. North America Bacteriophage Therapy Sales (K Units) by Type (2020-2033)
Table 35. North America Bacteriophage Therapy Market Size (M USD) by Type (2020-2033)
Table 36. North America Bacteriophage Therapy Sales by Application (K Units)
Table 37. North America Bacteriophage Therapy Market Size by Application (M USD)
Table 38. North America Bacteriophage Therapy Sales (K Units) by Application (2020-2033)
Table 39. North America Bacteriophage Therapy Market Size (M USD) by Application (2020-2033)
Table 40. Europe Bacteriophage Therapy Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Bacteriophage Therapy Sales by Country (2020-2033) & (K Units)
Table 42. Europe Bacteriophage Therapy Sales by Type (K Units)
Table 43. Europe Bacteriophage Therapy Market Size by Type (M USD)
Table 44. Europe Bacteriophage Therapy Sales (K Units) by Type (2020-2033)
Table 45. Europe Bacteriophage Therapy Market Size (M USD) by Type (2020-2033)
Table 46. Europe Bacteriophage Therapy Sales by Application (K Units)
Table 47. Europe Bacteriophage Therapy Market Size by Application (M USD)
Table 48. Europe Bacteriophage Therapy Sales (K Units) by Application (2020-2033)
Table 49. Europe Bacteriophage Therapy Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Bacteriophage Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Bacteriophage Therapy Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Bacteriophage Therapy Sales by Type (K Units)
Table 53. Asia-Pacific Bacteriophage Therapy Market Size by Type (M USD)
Table 54. Asia-Pacific Bacteriophage Therapy Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Bacteriophage Therapy Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Bacteriophage Therapy Sales by Application (K Units)
Table 57. Asia-Pacific Bacteriophage Therapy Market Size by Application (M USD)
Table 58. Asia-Pacific Bacteriophage Therapy Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Bacteriophage Therapy Market Size (M USD) by Application (2020-2025)
Table 60. South America Bacteriophage Therapy Market Size by Country (2020-2033) & (M USD)
Table 61. South America Bacteriophage Therapy Sales by Country (2020-2033) & (K Units)
Table 62. South America Bacteriophage Therapy Sales by Type (K Units)
Table 63. South America Bacteriophage Therapy Market Size by Type (M USD)
Table 64. South America Bacteriophage Therapy Sales (K Units) by Type (2020-2033)
Table 65. South America Bacteriophage Therapy Market Size (M USD) by Type (2020-2033)
Table 66. South America Bacteriophage Therapy Sales by Application (K Units)
Table 67. South America Bacteriophage Therapy Market Size by Application (M USD)
Table 68. South America Bacteriophage Therapy Sales (K Units) by Application (2020-2033)
Table 69. South America Bacteriophage Therapy Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Bacteriophage Therapy Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Bacteriophage Therapy Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Bacteriophage Therapy Sales by Type (K Units)
Table 73. Middle East and Africa Bacteriophage Therapy Market Size by Type (M USD)
Table 74. Middle East and Africa Bacteriophage Therapy Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Bacteriophage Therapy Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Bacteriophage Therapy Sales by Application (K Units)
Table 77. Middle East and Africa Bacteriophage Therapy Market Size by Application (M USD)
Table 78. Middle East and Africa Bacteriophage Therapy Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Bacteriophage Therapy Market Size (M USD) by Application (2020-2033)
Table 80. Global Bacteriophage Therapy Production (K Units) by Region(2020-2025)
Table 81. Global Bacteriophage Therapy Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Bacteriophage Therapy Revenue Market Share by Region (2020-2025)
Table 83. Global Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Bacteriophage Therapy Sales by Type (K Units)
Table 89. Global Bacteriophage Therapy Market Size by Type (M USD)
Table 90. Global Bacteriophage Therapy Sales (K Units) by Type (2020-2033)
Table 91. Global Bacteriophage Therapy Sales Market Share by Type (2020-2033)
Table 92. Global Bacteriophage Therapy Market Size (M USD) by Type (2020-2033)
Table 93. Global Bacteriophage Therapy Market Size Share by Type (2020-2033)
Table 94. Global Bacteriophage Therapy Sales (K Units) by Application
Table 95. Global Bacteriophage Therapy Market Size by Application(M USD)
Table 96. Global Bacteriophage Therapy Sales by Application (2020-2033) & (K Units)
Table 97. Global Bacteriophage Therapy Sales Market Share by Application (2020-2033)
Table 98. Global Bacteriophage Therapy Market Size by Application (2020-2033) & (M USD)
Table 99. Global Bacteriophage Therapy Market Share by Application (2020-2033)
Table 100. Global Bacteriophage Therapy Sales Growth Rate by Application (2020-2033)
Table 101. Armata Pharmaceuticals Basic Information
Table 102. Armata Pharmaceuticals Bacteriophage Therapy Product Overview
Table 103. Armata Pharmaceuticals Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Armata Pharmaceuticals Business Overview
Table 105. Armata Pharmaceuticals SWOT Analysis
Table 106. Armata Pharmaceuticals Recent Developments
Table 107. Inc. Basic Information
Table 108. Inc. Bacteriophage Therapy Product Overview
Table 109. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Inc. Business Overview
Table 111. Inc. SWOT Analysis
Table 112. Inc. Recent Developments
Table 113. Eliava Biopreparations Ltd. Basic Information
Table 114. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Overview
Table 115. Eliava Biopreparations Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Eliava Biopreparations Ltd. Business Overview
Table 117. Eliava Biopreparations Ltd. SWOT Analysis
Table 118. Eliava Biopreparations Ltd. Recent Developments
Table 119. Pherecydes Pharma Basic Information
Table 120. Pherecydes Pharma Bacteriophage Therapy Product Overview
Table 121. Pherecydes Pharma Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Pherecydes Pharma Business Overview
Table 123. Pherecydes Pharma Recent Developments
Table 124. Intralytix Basic Information
Table 125. Intralytix Bacteriophage Therapy Product Overview
Table 126. Intralytix Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Intralytix Business Overview
Table 128. Intralytix Recent Developments
Table 129. Inc. Basic Information
Table 130. Inc. Bacteriophage Therapy Product Overview
Table 131. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Inc. Business Overview
Table 133. Inc. Recent Developments
Table 134. Phagelux Inc. Basic Information
Table 135. Phagelux Inc. Bacteriophage Therapy Product Overview
Table 136. Phagelux Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Phagelux Inc. Business Overview
Table 138. Phagelux Inc. Recent Developments
Table 139. Nextbiotics Basic Information
Table 140. Nextbiotics Bacteriophage Therapy Product Overview
Table 141. Nextbiotics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Nextbiotics Business Overview
Table 143. Nextbiotics Recent Developments
Table 144. InnoPhage Basic Information
Table 145. InnoPhage Bacteriophage Therapy Product Overview
Table 146. InnoPhage Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. InnoPhage Business Overview
Table 148. InnoPhage Recent Developments
Table 149. Ltd Basic Information
Table 150. Ltd Bacteriophage Therapy Product Overview
Table 151. Ltd Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Ltd Business Overview
Table 153. Ltd Recent Developments
Table 154. Locus Biosciences Basic Information
Table 155. Locus Biosciences Bacteriophage Therapy Product Overview
Table 156. Locus Biosciences Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Locus Biosciences Business Overview
Table 158. Locus Biosciences Recent Developments
Table 159. Inc. Basic Information
Table 160. Inc. Bacteriophage Therapy Product Overview
Table 161. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Inc. Business Overview
Table 163. Inc. Recent Developments
Table 164. TechnoPhage Basic Information
Table 165. TechnoPhage Bacteriophage Therapy Product Overview
Table 166. TechnoPhage Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. TechnoPhage Business Overview
Table 168. TechnoPhage Recent Developments
Table 169. Eligo Bioscience SA Basic Information
Table 170. Eligo Bioscience SA Bacteriophage Therapy Product Overview
Table 171. Eligo Bioscience SA Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Eligo Bioscience SA Business Overview
Table 173. Eligo Bioscience SA Recent Developments
Table 174. Phagomed Biopharma GmbH. Basic Information
Table 175. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Overview
Table 176. Phagomed Biopharma GmbH. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Phagomed Biopharma GmbH. Business Overview
Table 178. Phagomed Biopharma GmbH. Recent Developments
Table 179. PhagePro Basic Information
Table 180. PhagePro Bacteriophage Therapy Product Overview
Table 181. PhagePro Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. PhagePro Business Overview
Table 183. PhagePro Recent Developments
Table 184. Inc. Basic Information
Table 185. Inc. Bacteriophage Therapy Product Overview
Table 186. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 187. Inc. Business Overview
Table 188. Inc. Recent Developments
Table 189. Adaptive Phage Therapeutics Basic Information
Table 190. Adaptive Phage Therapeutics Bacteriophage Therapy Product Overview
Table 191. Adaptive Phage Therapeutics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 192. Adaptive Phage Therapeutics Business Overview
Table 193. Adaptive Phage Therapeutics Recent Developments
Table 194. Inc. Basic Information
Table 195. Inc. Bacteriophage Therapy Product Overview
Table 196. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 197. Inc. Business Overview
Table 198. Inc. Recent Developments
Table 199. EnBiotix Basic Information
Table 200. EnBiotix Bacteriophage Therapy Product Overview
Table 201. EnBiotix Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 202. EnBiotix Business Overview
Table 203. EnBiotix Recent Developments
Table 204. Inc. Basic Information
Table 205. Inc. Bacteriophage Therapy Product Overview
Table 206. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 207. Inc. Business Overview
Table 208. Inc. Recent Developments
Table 209. Intodeworld Basic Information
Table 210. Intodeworld Bacteriophage Therapy Product Overview
Table 211. Intodeworld Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 212. Intodeworld Business Overview
Table 213. Intodeworld Recent Developments
Table 214. Inc. Basic Information
Table 215. Inc. Bacteriophage Therapy Product Overview
Table 216. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 217. Inc. Business Overview
Table 218. Inc. Recent Developments
Table 219. BiomX Ltd. Basic Information
Table 220. BiomX Ltd. Bacteriophage Therapy Product Overview
Table 221. BiomX Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 222. BiomX Ltd. Business Overview
Table 223. BiomX Ltd. Recent Developments
Table 224. Phi Therapeutics Basic Information
Table 225. Phi Therapeutics Bacteriophage Therapy Product Overview
Table 226. Phi Therapeutics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 227. Phi Therapeutics Business Overview
Table 228. Phi Therapeutics Recent Developments
Table 229. Fixed-phage Ltd. Basic Information
Table 230. Fixed-phage Ltd. Bacteriophage Therapy Product Overview
Table 231. Fixed-phage Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 232. Fixed-phage Ltd. Business Overview
Table 233. Fixed-phage Ltd. Recent Developments
Table 234. Micreos BV Basic Information
Table 235. Micreos BV Bacteriophage Therapy Product Overview
Table 236. Micreos BV Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 237. Micreos BV Business Overview
Table 238. Micreos BV Recent Developments
Table 239. ContraFect Corporation Basic Information
Table 240. ContraFect Corporation Bacteriophage Therapy Product Overview
Table 241. ContraFect Corporation Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 242. ContraFect Corporation Business Overview
Table 243. ContraFect Corporation Recent Developments
List of Figures
Figure 1. Product Picture of Bacteriophage Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bacteriophage Therapy Market Size (M USD), 2024-2033
Figure 5. Global Bacteriophage Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Bacteriophage Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bacteriophage Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Bacteriophage Therapy Product Life Cycle
Figure 13. Bacteriophage Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Bacteriophage Therapy Revenue Share by Manufacturers in 2024
Figure 15. Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Bacteriophage Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Bacteriophage Therapy Revenue in 2024
Figure 18. Industry Chain Map of Bacteriophage Therapy
Figure 19. Global Bacteriophage Therapy Market PEST Analysis
Figure 20. Global Bacteriophage Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Bacteriophage Therapy Market Size by Region
Figure 27. Global Bacteriophage Therapy Market Size Market Share by Region (2020-2033)
Figure 28. Global Bacteriophage Therapy Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Bacteriophage Therapy Market Size (M USD) by Country
Figure 33. USA Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Bacteriophage Therapy Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Bacteriophage Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Bacteriophage Therapy Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Bacteriophage Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Bacteriophage Therapy Market Size (M USD)by Type
Figure 40. North America Bacteriophage Therapy Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Bacteriophage Therapy Market Size (M USD) by Country
Figure 45. Germany Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Bacteriophage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Bacteriophage Therapy Market Size (M USD) by Type
Figure 56. Europe Bacteriophage Therapy Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Bacteriophage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Bacteriophage Therapy Market Size (M USD) by Country
Figure 61. China Bacteriophage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Bacteriophage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Bacteriophage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Bacteriophage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Bacteriophage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Bacteriophage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Bacteriophage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Bacteriophage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Bacteriophage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Bacteriophage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Bacteriophage Therapy Market Size (M USD) by Type
Figure 72. Asia-Pacific Bacteriophage Therapy Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Bacteriophage Therapy Market Size (M USD) by Country
Figure 77. Brazil Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Bacteriophage Therapy Market Size (M USD) by Type
Figure 84. South America Bacteriophage Therapy Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Bacteriophage Therapy Market Size (M USD) by Country
Figure 89. Saudi Arabia Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Bacteriophage Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Bacteriophage Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Bacteriophage Therapy Market Size (M USD) by Type
Figure 100. Middle East and Africa Bacteriophage Therapy Market Size (M USD) by Application
Figure 101. Global Bacteriophage Therapy Production Market Share by Region (2020-2025)
Figure 102. North America Bacteriophage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Bacteriophage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Bacteriophage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. China Bacteriophage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Bacteriophage Therapy Market Size by Type (M USD)
Figure 108. Sales Market Share of Bacteriophage Therapy by Type (2020-2033)
Figure 109. Sales Market Share of Bacteriophage Therapy by Type in 2024
Figure 110. Market Size Share of Bacteriophage Therapy by Type (2020-2033)
Figure 111. Market Size Share of Bacteriophage Therapy by Type in 2024
Figure 112. Global Bacteriophage Therapy Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Bacteriophage Therapy Market Size by Application(M USD)
Figure 115. Global Bacteriophage Therapy Market Share by Application
Figure 116. Global Bacteriophage Therapy Sales Market Share by Application (2020-2033)
Figure 117. Global Bacteriophage Therapy Sales Market Share by Application in 2024
Figure 118. Global Bacteriophage Therapy Market Share by Application (2020-2033)
Figure 119. Global Bacteriophage Therapy Market Share by Application in 2024
Figure 120. Global Bacteriophage Therapy Sales Growth Rate by Application (2020-2033)